The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A genomic classifier independently prognostic of prostate cancer death in a high-risk surgical cohort.
Matthew R. Cooperberg
Consultant or Advisory Role - GenomeDx Biosciences (U); Genomic Health (U)
Anamaria Crisan
Employment or Leadership Position - GenomeDx Biosciences
Anirban Pradip Mitra
Consultant or Advisory Role - GenomeDx Biosciences
Mercedeh Ghadessi
Employment or Leadership Position - GenomeDx Biosciences
Christine Buerki
Employment or Leadership Position - GenomeDx Biosciences
Elai Davicioni
Employment or Leadership Position - GenomeDx Biosciences
Stock Ownership - GenomeDx Biosciences